Risk of bias in studies investigating novel diagnostic biomarkers for heart failure with preserved ejection fraction. A systematic review

AIM: Diagnosing heart failure with preserved ejection fraction (HFpEF) in the non‐acute setting remains challenging. Natriuretic peptides have limited value for this purpose, and a multitude of studies investigating novel diagnostic circulating biomarkers have not resulted in their implementation. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Henkens, Michiel T.H.M., Remmelzwaal, Sharon, Robinson, Emma L., van Ballegooijen, Adriana J., Barandiarán Aizpurua, Arantxa, Verdonschot, Job A.J., Raafs, Anne G., Weerts, Jerremy, Hazebroek, Mark R., Sanders‐van Wijk, Sandra, Handoko, M. Louis, den Ruijter, Hester M., Lam, Carolyn S.P., de Boer, Rudolf A., Paulus, Walter J., van Empel, Vanessa P.M., Vos, Rein, Brunner‐La Rocca, Hans‐Peter, Beulens, Joline W.J., Heymans, Stephane R.B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd. 2020
Materias:
Biomarkers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689920/
https://www.ncbi.nlm.nih.gov/pubmed/32592317
http://dx.doi.org/10.1002/ejhf.1944

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689920/
https://www.ncbi.nlm.nih.gov/pubmed/32592317
http://dx.doi.org/10.1002/ejhf.1944

Ejemplares similares